SB 282: Compounding drugs; registration of medical spas. - Indiana

Senate Bill (S) → Senate Bill (H) · 4 edits

MODERATE

The bill was updated from a Senate version to an Engrossed version after passing both the Senate and House. The most significant change is the addition of House sponsors and a new requirement for medical spas to comply with specific advertising rules, which was not present in the earlier Senate draft. The bill's core purpose remains the same: regulating the compounding of GLP-1 drugs and requiring medical spas to register with the state.

Scope change

The bill's scope regarding medical spas has expanded slightly to include advertising compliance requirements, and the legislative history now reflects the bill's journey through the House of Representatives.

REQUIREMENT

Added a requirement for medical spas to comply with specific advertising regulations.

ELIGIBILITY

Added House sponsors (Barrett, McGuire, Porter) to the bill's sponsorship list.

TIMELINE

Updated the bill's effective date and history dates to reflect the final passage in late January 2026.

TECHNICAL

Updated the bill number designation from 'SB' to 'ES' (Engrossed Senate) and revised the digest summary to include new advertising and investigation provisions.

Enrolled Senate Bill (S) → Senate Bill (S) · 5 edits

MODERATE

The bill was converted from an enacted 'Senate Enrolled Act' into a 'Senate Bill', indicating it is now in the legislative process rather than being law. The substantive text regarding drug compounding and medical spa registration remains largely consistent, though the specific chapter title was slightly altered and the section numbering for definitions was expanded to include 'wholesale drug distributor'.

Scope change

The bill's scope remains focused on regulating the compounding of GLP-1 drugs and registering medical spas, with no change to the core policy goals.

TIMELINE

The header indicating the bill was already enacted as 'Senate Enrolled Act No. 282' was removed.

TECHNICAL

A detailed digest and synopsis summarizing the bill's provisions regarding drug restrictions and medical spa registration were added.

The bill's procedural history was updated to reflect its current status as SB 282, including committee referral and reporting dates in January 2026.

The title of the new drug regulation chapter was changed from 'Restrictions on Bulk Drug Substances' to 'Restrictions on Certain Bulk Drug Substances'.

DEFINITION

A new definition for 'wholesale drug distributor' was added to the list of terms defined in the bill.

Engrossed Senate Bill (S) → Enrolled Senate Bill (S) · 3 edits · Mar 5, 2026

MINOR

The bill text was converted from an 'Engrossed' draft to an 'Enrolled' final version, which involves significant formatting updates and the addition of a concurrence stamp indicating the bill has passed both legislative chambers. The actual legal text, including definitions for drug compounding and new restrictions on bulk drug substances, remains substantively identical between the two versions.

Scope change

The scope of the bill's legal provisions did not change; only the document's status and formatting were updated to reflect final passage.

TECHNICAL

The document header was updated from 'Engrossed Senate Bill' to 'Senate Enrolled Act,' reflecting that the bill has been signed into law.

The legislative history section was replaced with a 'Concur' stamp, indicating the bill has been concurred in by the House of Representatives.

Page numbering and line spacing were adjusted to match the standard format for enrolled acts.

Engrossed Senate Bill (H) → Engrossed Senate Bill (S) · 4 edits · Feb 26, 2026

MODERATE

The bill was amended to expand its scope by adding new definitions for drug compounding and bulk drug substances, and by requiring agencies to report on the risks and benefits of compounding. It also updated the affected code citations to reflect these new additions and clarified the regulatory framework for pharmacies and medical spas.

Scope change

The bill's scope was broadened to include specific definitions for 'bulk drug substance' and 'compounding' and to mandate a report on compounding risks and benefits, in addition to the original requirements for pharmacy compliance and medical spa registration.

DEFINITION

Added new definitions for 'bulk drug substance' and 'compounding' to clarify what substances and actions are regulated under the new chapter.

REQUIREMENT

Added a requirement for specified agencies to prepare a report concerning drug compounding, including its risks and benefits.

ENFORCEMENT

Expanded the board's enforcement powers to allow investigation of responsible practitioners and forwarding substantiated claims to their governing boards.

TECHNICAL

Updated the list of affected Indiana Code citations to include new sections and chapters related to the added definitions and requirements.

Introduced Senate Bill (S) → Engrossed Senate Bill (H) · 6 edits · Feb 26, 2026

MODERATE

The bill was substantially rewritten to shift its primary focus from regulating drug compounding to enforcing federal compliance for specific pharmacies and establishing a new registration system for medical spas. The original text, which detailed restrictions on bulk drug substances, was replaced with language requiring certain pharmacies to adhere to federal Food, Drug, and Cosmetic Act standards. Additionally, the medical spa section was updated to require registration under the medical licensing board and added specific prohibitions on where these services can be provided.

Scope change

The bill's scope changed from a broad regulation of drug compounding and medical spas to a targeted enforcement mechanism for specific pharmacy types (503A and 503B) and a new registration requirement for medical spas.

SCOPE

The bill's main focus shifted from restricting the compounding of drugs using bulk substances to requiring specific pharmacies to comply with federal FDA regulations (Sections 503A and 503B).

REQUIREMENT

A new requirement was added for medical spas to register with the medical licensing board of Indiana, replacing the previous requirement to register with the board of pharmacy.

The definition of a medical spa was expanded to include specific cosmetic and lifestyle treatments like weight loss, wellness, and hormone therapies.

New restrictions were added prohibiting medical spas from providing health care services or cosmetic treatments in locations other than the spa, a physician's office, or another health care facility.

DEFINITION

Detailed definitions for 'bulk drug substance' and 'bulk drug substance manufacturing establishment' were removed from the text.

ENFORCEMENT

Enforcement authority was updated to allow the board of pharmacy to investigate and enforce compliance with federal pharmacy laws for specific pharmacy types.

Compounding drugs; registration of medical spas.

What changed between versions

How they voted

Actions timeline

Sponsors